Free Trial

Alto Neuroscience (ANRO) SEC Filings & 10K Form

Alto Neuroscience logo
$4.09 +0.09 (+2.25%)
(As of 12/24/2024 04:45 PM ET)

Recent Alto Neuroscience SEC Filings

DateFilerForm TypeView
11/14/2024
4:46 PM
Alto Neuroscience (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
6:00 AM
Alto Neuroscience (Subject)
Etkin Amit (Filed by)
Form SC 13G
10/22/2024
3:35 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
3:11 PM
Alto Neuroscience (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
08/13/2024
3:33 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:36 PM
Alto Neuroscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2024
3:19 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
4:19 PM
Alto Neuroscience (Issuer)
Hanley Jr. Michael Conick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:29 AM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
3:15 PM
Alto Neuroscience (Issuer)
Smith Nicholas Conrad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
11:54 AM
Alto Neuroscience (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
03/21/2024
3:19 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
3:49 PM
Alto Neuroscience (Issuer)
Radhakrishnan Maha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
3:47 PM
Alto Neuroscience (Issuer)
Radhakrishnan Maha (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/11/2024
7:20 AM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
8:15 AM
Alto Neuroscience (Issuer)
Angermayer Christian (Reporting)
Apeiron Investment Group Ltd. (Reporting)
Apeiron Presight Capital Fund II, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:00 PM
Alto Neuroscience (Issuer)
Etkin Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:00 PM
Alto Neuroscience (Issuer)
Smith Nicholas Conrad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:00 PM
Alto Neuroscience (Issuer)
Savitz Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
8:31 AM
Alpha Wave Global, LP (Filed by)
Alto Neuroscience (Subject)
Form SC 13G
02/07/2024
3:25 PM
Alto Neuroscience (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
02/06/2024
3:56 PM
Alto Neuroscience (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/05/2024
3:40 PM
Alto Neuroscience (Issuer)
Dreyfus Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:42 PM
Alto Neuroscience (Issuer)
Cox Christopher Nixon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:43 PM
Alto Neuroscience (Issuer)
Chen Po Yu (0002008609) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:45 PM
Alto Neuroscience (Issuer)
Manji Husseini (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:47 PM
Alto Neuroscience (Issuer)
York Gwill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:02 AM
Alto Neuroscience (Filer)
Form 424B4
02/02/2024
3:54 PM
Alto Neuroscience (Issuer)
Angermayer Christian (Reporting)
Apeiron Investment Group Ltd. (Reporting)
Apeiron Presight Capital Fund II, L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
11:15 PM
Alto Neuroscience (Filer)
Form EFFECT
02/01/2024
5:53 PM
Alpha Wave Global, LP (Reporting)
Alpha Wave Ventures GP, Ltd (Reporting)
Alto Neuroscience (Issuer)
Chimera Investment LLC (Reporting)
Lunate Holding RSC Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:53 PM
Alto Neuroscience (Issuer)
Dreyfus Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:55 PM
Alto Neuroscience (Issuer)
Manji Husseini (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:43 PM
Alto Neuroscience (Issuer)
Chen Po Yu (0002008609) (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:45 PM
Alto Neuroscience (Issuer)
Savitz Adam (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:47 PM
Alto Neuroscience (Issuer)
Cox Christopher Nixon (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:47 PM
ALKEON CAPITAL MANAGEMENT LLC (Reporting)
Alto Neuroscience (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:48 PM
Alto Neuroscience (Issuer)
Smith Nicholas Conrad (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:50 PM
Alto Neuroscience (Issuer)
York Gwill (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:52 PM
Alto Neuroscience (Issuer)
Etkin Amit (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:26 PM
Alto Neuroscience (Filer)
Form S-1MEF
No one’s talking about these Trump trades (Ad)

As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”

Go here to see how you can start accessing these opportunities today
01/30/2024
3:02 PM
Alto Neuroscience (Filer)
Form 8-A12B
01/29/2024
9:35 AM
Alto Neuroscience (Filer)
Form S-1/A
01/29/2024
6:36 AM
Alto Neuroscience (Filer)
Form S-1/A
01/12/2024
3:50 PM
Alto Neuroscience (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ANRO) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners